The Medicare Drug Payment Model Worsens a Bad Situation

According to the American Society of Clinical Oncology (ASCO), the proposal by the Centers for Medicare & Medicaid Services that will change the way Medicare pays for drugs under Part B program could/will hurt oncologists.

ASCO states that oncologists do not receive enough reimbursement from Medicare on many cancer drugs to cover the cost of acquire them.   They believe this is a misguided attempt to control the high cost of drugs by putting the burden on the backs of the providers. Read the article here……

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.